The lymphatic system performs essential physiological functions for protein homeostasis and immune surveillance; hence, the apparent absence of conventional lymphatic vessels from the CNS has remained a persistent mystery of neur oscience, particularly in light of the exquisite sensitivity of neurons to the composition of their extracellular environment.
It has long been appreciated that the CSF circulation serves an excretory role, functioning as a sink for metabolic waste produced within the CNS that cannot be readily eliminated across the blood-brain barrier. In a model initially articulated by Davson and Segal, 1 and later elaborated by Cserr, 2 interstitial solutes in the brain exchange with the CSF through local diff usion and interstitial fl uid bulk fl ow, and are cleared from the cranium with CSF reabsorption. In 1914, Weed 3 established a model of CSF reabsorption that has persisted largely intact to the present day: CSF can exit the subarachnoid space into the dural sinuses via the arachnoid granulations and into peripheral lymphatic vessels of the nasal mucosa and neck along perineural spaces surrounding the cranial nerves. Although presumptive primary lymphatic vessels have been previously identifi ed within the dura and implicated in CSF reabsorption, 4 Weed's assertion that "the absence of meningeal lymphatics has been proved" 3 has remained a basic tenet of neuroscience.
Two key independent studies now show that, contrary to this long-held belief, the brain is indeed served by lymphatic vessels associated with the dural sinuses, which are venous structures situated in the membrane between the brain surface and the skull.
Both the study by Louveau and colleagues 5 and the study of Aspelund and colleagues 6 reported the presence of sinus-associated vascular structures that express markers of lymphatic endothelial cells, including LYVE1, PROX1, and VEGFR3, but are not labelled with intravenous tracers, showing that these vessels are not elements of the blood vasculature. Whereas both studies document the association between these putative lymphatic vessels and the superior sagittal and transverse sinuses, the more complete anatomical characterisation done by Aspelund and colleagues 6 shows that these vessels are also associated with the dural middle meningeal arteries, and exit the cranium along both veins and arteries (fi gure).
Louveau and colleagues 5 reported that quantum dots were rapidly cleared from the CSF into these sinusassociated vessels, whereas Aspelund and colleagues 6 observed that fl uorescently labelled polyethylene glycol tracers were cleared rapidly from the brain interstitium to the same vessels. Both studies reported that these lymphatic vessels transport solutes to deep cervical lymph nodes, providing an anatomical link between the brain interstitial and CSF compartments and the periphery. Genetic ablation of the dural lymphatic vasculature in mice slowed the clearance of tracers injected into the brain interstitium and prevented them from reaching the deep cervical lymph nodes, showing that the clearance of solutes from the brain interstitium was dependent upon their movement along these sinus-associated lymphatic vessels. 6 One caveat shared by both studies is their implication that cervical nodes provide an intermediate way-station for fl uid travelling from the brain interstitial space to the systemic circulation. This scheme is inconsistent with the lack of clinical association between meningeal and cerebral infections and cervical adenopathy in human beings. As such, the specifi c anatomical pathways mediating meningeal lymphatic access to the systemic circulation have yet to be fully defi ned in human beings, an avenue of likely fruitful research to come.
The fi ndings from these two studies complement those from our group describing a brain-wide perivascular pathway that supports the exchange of CSF and interstitial fl uid. We have found that subarachnoid CSF recirculates into and through the brain interstitium along perivascular spaces surrounding cerebral arteries, whereas interstitial solutes are cleared from the brain along perivascular channels surrounding large-calibre draining veins. 7, 8 Because perivascular CSF recirculation and interstitial solute clearance is mediated in part by astroglial intermediaries, and requires the astroglial water channel aquaporin-4, this pathway for interstitial solute clearance was designated the glymphatic system.
The sinus-associated lymphatic vessels and the glymphatic pathway might connect to comprise one anatomically continuous and functionally seamless system. In our studies, we repeatedly observed that tracers and proteins injected into the brain parenchyma are cleared along specifi c anatomical routes-following Implications of the discovery of brain lymphatic pathways white matter tracts and large-calibre draining veins that emptied into sinus-associated cisternal compartments. 7, 9, 10 For example, tracers injected into the cortex and striatum drained in part along the medial internal cerebral veins, and ultimately along the internal jugular circulation.
The drainage of interstitial solutes along the perivenous spaces of the glymphatic pathway seem to provide these solutes access to the sinus-associated lymphatics either directly, as these large veins merge to form the dural sinuses, or indirectly via the cisternal CSF compartments. It might be therefore appropriate to regard these two components (the perivascular pathways within the CNS parenchyma and the extra-axial meningeal lymphatic vessels) as serial elements of a functional system. One element supports the clearance of solutes from the brain to the CSF, whereas the other propels that solute-laden CSF on to the systemic vascular system. The interaction between the perivascular glymphatic pathway and the sinus-associated lymphatic vessels might also play a part in immune surveillance of the CNS by peripheral immune cells. Louveau and colleagues 5 reported that T lymphocytes were strongly associated with lymphatic vessels in the brain. Ligation of the collecting vessels draining to the deep cervical lymph nodes resulted in the distension of the dural lymphatic vessels and the accumulation of T lymphocytes, suggesting that these vessels provide a pathway for the movement of immune cells out of the cranium. The clearance of interstitial solutes, presumably along perivascular pathways, to peripheral lymph nodes outside the brain parenchyma suggests that this pathway might play a part in antigen presentation and immune surveillance of the CNS, even while maintaining the relative immune privilege of the brain parenchyma. The dynamic movement of CSF through perivascular spaces, the brain parenchyma, and the lymph vessels can be traced by injection of fluorescent markers (green), injected into the cisterna magna.
CSF from the subarachnoid space is driven in along the periarterial space by arterial pulsatility Interstitial fluid collects in the perivenous spaces, from which it is transported back to the general circulation, via meningeal and cervical lymph vessels Although these two studies describing dura-associated lymphatic vessels represent an important step towards understanding the basic biological function of the brain, important caveats remain. Functionally, the contribution of these lymphatic pathways to the clearance of interstitial and CSF solutes (relative to the better known effl ux pathways of dural arachnoid granulations and perineural sheathes) is unclear. Do these diff erent clearance pathways have functionally distinct roles, for instance, solute clearance versus immune surveillance? How are these effl ux pathways modulated by physiological variation? Glymphatic function, and thus interstitial protein waste clearance, is primarily active during sleep.
10 Does interstitial solute clearance and immune cell traffi cking manifest similar diurnal variation?
The roles of these effl ux pathways in brain interstitial solute clearance and immune cell traffi cking suggest their involvement in diseases as diverse as the proteinopathies and immune demyelination. Amyloid clearance in Alzheimer's disease, alpha-synuclein clearance in Parkinson's disease, Lewy body disease, and multisystem atrophy, and indeed the progression of all prion-like proteinopathies, might be aff ected by the functional competence of these effl ux pathways. Their dysfunction could suppress not only solute clearance, but also fl uid effl ux itself, as might be predicted in conditions as diverse as primary intracranial hypertension and glaucoma. Likewise, immune surveillance of agents leaving the brain could comprise a previously unrecognised strategy for mobilising immune cells against foreign antigens that invade the brain; such a mechanism might lead to rethinking our understanding of T-cell activation and traffi cking in multiple sclerosis, as well as the strategies by which those processes might be therapeutically targeted. Of course, it is important to remember that functional studies of both the glymphatic and meningeal lymphatic systems have thus far been restricted to animal models. Although the report by Louveau and colleagues 5 provided evidence for sinus-associated lymphatic structures in human tissue, the specifi c anatomy and relative functional importance of these clearance systems in human disease have yet to be assessed. This research will provide a wealth of new insight in the coming years, as the causal relations between the fl uid dynamics of the brain and brain disorders become better understood and therapeutically exploited.
